Root Financial Partners’s Vir Biotechnology VIR Stock Holding History

Root Financial Partners’s Portfolio VIR Stock Details VIR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-243	Closed	-$2.18K	–	3093
2026 Q1	$2.18K	Buy	+243	New	+$1.94K	﹤0.01%	2281

Other funds holding VIR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AVM

Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

SIAU

SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

GSK plc London $602M AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Root Financial Partners's VIR Position: Q2 2026 in Review

Root Financial Partners sold out of Vir Biotechnology (VIR) in Q2 2026, closing a stake of 243 shares — an estimated $2.18K sold.

Root Financial Partners first reported a position in VIR in Q1 2026 and held it in 1 quarter. The position peaked at $2.18K in Q1 2026. 237 funds tracked by Wall St. Rank hold VIR as of Q2 2026.

Root Financial Partners reported no remaining Vir Biotechnology position as of Q2 2026 after selling out during the quarter.
Root Financial Partners sold 243 Vir Biotechnology shares in Q2 2026, an estimated $2.18K.
Root Financial Partners first reported a position in Vir Biotechnology in Q1 2026 and held it in 1 quarter.
Root Financial Partners's Vir Biotechnology position peaked at $2.18K in Q1 2026.
237 funds tracked by Wall St. Rank held Vir Biotechnology as of Q2 2026.

Based on Root Financial Partners's 13F filing for Q2 2026, filed 29 Jul 2026.